Timothy Kieffer
Chief Tech/Sci/R&D Officer at FRACTYL HEALTH, INC.
Net worth: - $ as of 30/06/2024
Timothy Kieffer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FRACTYL HEALTH, INC. | Chief Tech/Sci/R&D Officer | 01/09/2023 | - |
Career history of Timothy Kieffer
Former positions of Timothy Kieffer
| Companies | Position | Start | End |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/09/2021 | 01/10/2022 |
| University of British Columbia | Corporate Officer/Principal | 01/01/2007 | - |
Training of Timothy Kieffer
| University of British Columbia | Doctorate Degree |
Statistics
International
| United States | 3 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FRACTYL HEALTH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Kieffer
- Experience
